Bonefos Tablets
Last Updated on eMC 23-Jun-2016 View document | Bayer plc Contact details
Versions
- 23-Jun-2016 to Current
- 08-Jan-2016 to 23-Jun-2016
- 04-Aug-2014 to 08-Jan-2016
- 09-Jul-2013 to 04-Aug-2014
- 26-Aug-2011 to 09-Jul-2013
- 10-May-2011 to 26-Aug-2011
- 15-Mar-2011 to 10-May-2011
- 25-Nov-2010 to 15-Mar-2011
- 24-Jun-2008 to 25-Nov-2010
- 03-Aug-2007 to 24-Jun-2008
- 08-Dec-2006 to 03-Aug-2007
- 05-Jan-2006 to 08-Dec-2006
- 01-Jul-2003 to 05-Jan-2006
- 28-Sep-2000 to 01-Jul-2003
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 23-Jun-2016 and displayed until Current
Reasons for adding or updating:
- Change to section 4 - possible side effects
Updated on 08-Jan-2016 and displayed until 23-Jun-2016
Reasons for adding or updating:
- Change to section 1 - what the product is
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 3 - how to take/use
- Change to section 3 - overdose, missed or forgotten doses
- Change to section 5 - how to store
Updated on 04-Aug-2014 and displayed until 08-Jan-2016
Reasons for adding or updating:
- Change to section 3 - how to take/use
- Change to section 3 - overdose, missed or forgotten doses
- Change to section 6 - date of revision
Updated on 09-Jul-2013 and displayed until 04-Aug-2014
Reasons for adding or updating:
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 4 - possible side effects
- Change to section 6 - marketing authorisation holder
Updated on 26-Aug-2011 and displayed until 09-Jul-2013
Reasons for adding or updating:
- Change to date of revision
- Change to side-effects
Updated on 10-May-2011 and displayed until 26-Aug-2011
Reasons for adding or updating:
- Change of inactive ingredient
- Change to date of revision
Updated on 15-Mar-2011 and displayed until 10-May-2011
Reasons for adding or updating:
- Change to date of revision
- Change to manufacturer contact details
Updated on 25-Nov-2010 and displayed until 15-Mar-2011
Reasons for adding or updating:
- Change to dosage and administration
Updated on 24-Jun-2008 and displayed until 25-Nov-2010
Reasons for adding or updating:
- Change to Marketing Authorisation Holder
- Change to date of revision
- Change of licence holder
- Change to MA holder contact details
Updated on 03-Aug-2007 and displayed until 24-Jun-2008
Reasons for adding or updating:
- Change to date of revision
- Change to name of manufacturer
Updated on 08-Dec-2006 and displayed until 03-Aug-2007
Reasons for adding or updating:
- Change to warnings or special precautions for use
- Change to date of revision
Updated on 05-Jan-2006 and displayed until 08-Dec-2006
Reasons for adding or updating:
- Change of Marketing Authorisation Holder
Updated on 01-Jul-2003 and displayed until 05-Jan-2006
Reasons for adding or updating:
- Change to Marketing Authorisation Holder
- Update to PIL
Updated on 28-Sep-2000 and displayed until 01-Jul-2003
Reasons for adding or updating:
- No reasons supplied
Bayer plc
Bayer House, Strawberry Hill, Newbury, Berkshire, RG14 1JA
+44 (0)1635 563 393
+44 (0)1635 563 000
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue